Qianbin Sun

459 total citations
15 papers, 341 citations indexed

About

Qianbin Sun is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Qianbin Sun has authored 15 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Qianbin Sun's work include Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Electron Spin Resonance Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Qianbin Sun is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Electron Spin Resonance Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Qianbin Sun collaborates with scholars based in China and United States. Qianbin Sun's co-authors include Xiaoping Wang, Yong Wang, Chun Li, Yanyan Jiang, Qiyan Wang, Weili Li, Qianqian Jiang, Jing Cao, Xue Tian and Yawen Zhang and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and Frontiers in Pharmacology.

In The Last Decade

Qianbin Sun

15 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qianbin Sun China 12 169 146 63 47 42 15 341
Weili Li China 13 249 1.5× 200 1.4× 86 1.4× 48 1.0× 93 2.2× 19 499
Xiaoyang Huang China 11 203 1.2× 75 0.5× 38 0.6× 16 0.3× 42 1.0× 14 388
Zhulan Cai China 12 251 1.5× 127 0.9× 26 0.4× 27 0.6× 44 1.0× 16 425
Xue Tian China 12 130 0.8× 72 0.5× 24 0.4× 24 0.5× 27 0.6× 27 282
László Deres Hungary 12 230 1.4× 93 0.6× 68 1.1× 25 0.5× 14 0.3× 20 498
Yuyang Zheng China 12 215 1.3× 96 0.7× 28 0.4× 27 0.6× 11 0.3× 15 357
Wencong Tian China 11 158 0.9× 72 0.5× 56 0.9× 28 0.6× 25 0.6× 19 321
Sarhene Michael China 7 191 1.1× 156 1.1× 26 0.4× 13 0.3× 39 0.9× 9 389

Countries citing papers authored by Qianbin Sun

Since Specialization
Citations

This map shows the geographic impact of Qianbin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianbin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianbin Sun more than expected).

Fields of papers citing papers by Qianbin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianbin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianbin Sun. The network helps show where Qianbin Sun may publish in the future.

Co-authorship network of co-authors of Qianbin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Qianbin Sun. A scholar is included among the top collaborators of Qianbin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianbin Sun. Qianbin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Li, Weili, Yuqin Zhang, Wei Yan, et al.. (2024). New insights into mitochondrial quality control in anthracycline-induced cardiotoxicity: molecular mechanisms, therapeutic targets, and natural products. International Journal of Biological Sciences. 21(2). 507–523. 2 indexed citations
2.
Liu, Tiantian, Qianbin Sun, Junjun Li, et al.. (2024). Valerenic acid attenuates pathological myocardial hypertrophy by promoting the utilization of multiple substrates in the mitochondrial energy metabolism. Journal of Advanced Research. 68. 241–256. 10 indexed citations
3.
Chen, Huan, Jingmei Zhang, Ran Tian, et al.. (2024). Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway. Journal of Ethnopharmacology. 335. 118604–118604. 13 indexed citations
4.
Guo, Dongqing, Jincheng Guo, Qianbin Sun, et al.. (2024). Activation of the Macrophage-Associated Inflammasome Exacerbates Myocardial Fibrosis Through the 15-HETE-Mediated Pathway in Acute Myocardial Infarction. Engineering. 42. 143–156. 3 indexed citations
5.
Zhang, Jingmei, Weili Li, Huan Chen, et al.. (2023). Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3. Journal of Ethnopharmacology. 319(Pt 1). 117134–117134. 20 indexed citations
6.
Jiang, Qianqian, Xue Tian, Jingmei Zhang, et al.. (2022). Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway. Phytomedicine. 106. 154439–154439. 83 indexed citations
7.
Li, Weili, Xiaoping Wang, Tianhua Liu, et al.. (2022). Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy. Frontiers in Cell and Developmental Biology. 10. 813370–813370. 29 indexed citations
8.
Wang, Xiaoping, Yanyan Jiang, Yawen Zhang, et al.. (2022). The roles of the mitophagy inducer Danqi pill in heart failure: A new therapeutic target to preserve energy metabolism. Phytomedicine. 99. 154009–154009. 14 indexed citations
9.
Wang, Xiaoping, Weili Li, Yawen Zhang, et al.. (2022). Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT–IKK/STAT3 Axis. Frontiers in Pharmacology. 13. 828061–828061. 42 indexed citations
10.
Tian, Xue, Qianqian Jiang, Qianbin Sun, et al.. (2022). Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway. Frontiers in Pharmacology. 13. 864326–864326. 24 indexed citations
11.
Wang, Xiaoping, Jing Cao, Weili Li, et al.. (2022). Mechanisms and Drug Intervention for Doxorubicin‐Induced Cardiotoxicity Based on Mitochondrial Bioenergetics. Oxidative Medicine and Cellular Longevity. 2022(1). 7176282–7176282. 25 indexed citations
12.
Li, Weili, Yawen Zhang, Xiaoping Wang, et al.. (2022). Qishen Granule Protects against Doxorubicin‐Induced Cardiotoxicity by Coordinating MDM2‐p53‐Mediated Mitophagy and Mitochondrial Biogenesis. Oxidative Medicine and Cellular Longevity. 2022(1). 4344677–4344677. 12 indexed citations
13.
Wang, Xiaoping, Qianbin Sun, Qianqian Jiang, et al.. (2021). Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro. Molecules. 26(5). 1460–1460. 31 indexed citations
14.
Li, Weili, Jing Cao, Xiaoping Wang, et al.. (2021). Ferruginol Restores SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis and Fatty Acid Oxidation for the Treatment of DOX-Induced Cardiotoxicity. Frontiers in Pharmacology. 12. 773834–773834. 20 indexed citations
15.
Wang, Xiaoping, Yanyan Jiang, Qian Zhang, et al.. (2020). Autophagy as a novel insight into mechanism of Danqi pill against post-acute myocardial infarction heart failure. Journal of Ethnopharmacology. 266. 113404–113404. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026